Published in Circ Res on June 22, 2007
Microenvironmental regulation of tumor progression and metastasis. Nat Med (2013) 8.37
Contribution of platelets to tumour metastasis. Nat Rev Cancer (2011) 4.16
Mechanoenzymatic cleavage of the ultralarge vascular protein von Willebrand factor. Science (2009) 3.85
In vitro microvessels for the study of angiogenesis and thrombosis. Proc Natl Acad Sci U S A (2012) 3.61
A shear gradient-dependent platelet aggregation mechanism drives thrombus formation. Nat Med (2009) 3.57
Triggers, targets and treatments for thrombosis. Nature (2008) 3.51
Structural specializations of A2, a force-sensing domain in the ultralarge vascular protein von Willebrand factor. Proc Natl Acad Sci U S A (2009) 1.91
A mechanically stabilized receptor-ligand flex-bond important in the vasculature. Nature (2010) 1.90
In vitro modeling of the microvascular occlusion and thrombosis that occur in hematologic diseases using microfluidic technology. J Clin Invest (2011) 1.89
Talin-dependent integrin activation is required for fibrin clot retraction by platelets. Blood (2010) 1.83
Programmable 3D silk bone marrow niche for platelet generation ex vivo and modeling of megakaryopoiesis pathologies. Blood (2015) 1.79
Deadly allies: the fatal interplay between platelets and metastasizing cancer cells. Blood (2010) 1.67
Association of abacavir and impaired endothelial function in treated and suppressed HIV-infected patients. AIDS (2009) 1.67
Platelet receptors and signaling in the dynamics of thrombus formation. Haematologica (2009) 1.65
Distinct spatio-temporal Ca2+ signaling elicited by integrin alpha2beta1 and glycoprotein VI under flow. Blood (2009) 1.57
Platelet glycoprotein Ib-IX as a regulator of systemic inflammation. Arterioscler Thromb Vasc Biol (2014) 1.50
Impaired alpha(IIb)beta(3) integrin activation and shear-dependent thrombus formation in mice lacking phospholipase D1. Sci Signal (2010) 1.49
Grow with the flow: a spatial-temporal model of platelet deposition and blood coagulation under flow. Math Med Biol (2010) 1.47
Thrombin and collagen induce a feedback inhibitory signaling pathway in platelets involving dissociation of the catalytic subunit of protein kinase A from an NFkappaB-IkappaB complex. J Biol Chem (2010) 1.47
A novel interaction between FlnA and Syk regulates platelet ITAM-mediated receptor signaling and function. J Exp Med (2010) 1.45
Highly reinforced structure of a C-terminal dimerization domain in von Willebrand factor. Blood (2014) 1.44
Platelets contribute to postnatal occlusion of the ductus arteriosus. Nat Med (2009) 1.41
A pH-regulated dimeric bouquet in the structure of von Willebrand factor. EMBO J (2011) 1.34
Biology and physics of von Willebrand factor concatamers. J Thromb Haemost (2011) 1.33
Platelet adhesion under flow. Microcirculation (2009) 1.31
Microfluidics and coagulation biology. Annu Rev Biomed Eng (2013) 1.30
Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum. Semin Immunopathol (2011) 1.26
Sequence and structure relationships within von Willebrand factor. Blood (2012) 1.26
Synergism between platelet collagen receptors defined using receptor-specific collagen-mimetic peptide substrata in flowing blood. Blood (2010) 1.17
Blood flow and coherent vortices in the normal and aneurysmatic aortas: a fluid dynamical approach to intra-luminal thrombus formation. J R Soc Interface (2011) 1.16
von Willebrand factor, Jedi knight of the bloodstream. Blood (2014) 1.15
Cloning, expression, and hemostatic activities of a disintegrin, r-mojastin 1, from the mohave rattlesnake (Crotalus scutulatus scutulatus). Thromb Res (2010) 1.11
Hyperglycemia-induced cerebral hematoma expansion is mediated by plasma kallikrein. Nat Med (2011) 1.10
Leucocyte/endothelium interactions and microvessel permeability: coupled or uncoupled? Cardiovasc Res (2010) 1.08
Thrombocytopenia in Dengue: Interrelationship between Virus and the Imbalance between Coagulation and Fibrinolysis and Inflammatory Mediators. Mediators Inflamm (2015) 1.05
Platelet adhesion from shear blood flow is controlled by near-wall rebounding collisions with erythrocytes. Biophys J (2011) 1.04
Identification of platelet function defects by multi-parameter assessment of thrombus formation. Nat Commun (2014) 1.03
Fluid shear induces conformation change in human blood protein von Willebrand factor in solution. Biophys J (2009) 1.03
Using microcontact printing of fibrinogen to control surface-induced platelet adhesion and activation. Langmuir (2011) 1.02
Ginsenoside-Rp1 inhibits platelet activation and thrombus formation via impaired glycoprotein VI signalling pathway, tyrosine phosphorylation and MAPK activation. Br J Pharmacol (2012) 1.01
Human platelets recognize a novel surface protein, PadA, on Streptococcus gordonii through a unique interaction involving fibrinogen receptor GPIIbIIIa. Infect Immun (2009) 1.00
High content evaluation of shear dependent platelet function in a microfluidic flow assay. Ann Biomed Eng (2012) 1.00
Platelet mimetic particles for targeting thrombi in flowing blood. Adv Mater (2012) 0.98
Binding of alpha-thrombin to surface-anchored platelet glycoprotein Ib(alpha) sulfotyrosines through a two-site mechanism involving exosite I. Proc Natl Acad Sci U S A (2011) 0.98
Structural basis of regulation of von Willebrand factor binding to glycoprotein Ib. J Biol Chem (2014) 0.97
The N-terminal flanking region of the A1 domain regulates the force-dependent binding of von Willebrand factor to platelet glycoprotein Ibα. J Biol Chem (2013) 0.97
Advances in alloimmune thrombocytopenia: perspectives on current concepts of human platelet antigens, antibody detection strategies, and genotyping. Blood Transfus (2015) 0.96
Amorphous silica nanoparticles aggregate human platelets: potential implications for vascular homeostasis. Int J Nanomedicine (2012) 0.95
The role of Rac1 in glycoprotein Ib-IX-mediated signal transduction and integrin activation. Arterioscler Thromb Vasc Biol (2012) 0.92
Phosphoinositide 3-kinase p110 beta regulates integrin alpha IIb beta 3 avidity and the cellular transmission of contractile forces. J Biol Chem (2009) 0.92
Endothelial progenitor cells bind and inhibit platelet function and thrombus formation. Circulation (2009) 0.92
Control of integrin alphaIIb beta3 outside-in signaling and platelet adhesion by sensing the physical properties of fibrin(ogen) substrates. Biochemistry (2010) 0.92
Finite platelet size could be responsible for platelet margination effect. Biophys J (2011) 0.91
State of the art in platelet function testing. Transfus Med Hemother (2013) 0.90
Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells. Mediators Inflamm (2010) 0.90
Platelet glycoprotein Ibα ectodomain shedding and non-surgical bleeding in heart failure patients supported by continuous-flow left ventricular assist devices. J Heart Lung Transplant (2013) 0.89
Role for platelet glycoprotein Ib-IX and effects of its inhibition in endotoxemia-induced thrombosis, thrombocytopenia, and mortality. Arterioscler Thromb Vasc Biol (2013) 0.89
Effects of danshensu on platelet aggregation and thrombosis: in vivo arteriovenous shunt and venous thrombosis models in rats. PLoS One (2014) 0.89
The P2X1 receptor and platelet function. Purinergic Signal (2011) 0.89
Animal models of hemophilia and related bleeding disorders. Semin Hematol (2013) 0.89
Serotonin stimulates platelet receptor shedding by tumor necrosis factor-alpha-converting enzyme (ADAM17). J Thromb Haemost (2009) 0.89
LIM kinase-1 selectively promotes glycoprotein Ib-IX-mediated TXA2 synthesis, platelet activation, and thrombosis. Blood (2013) 0.88
An integrated fluid-chemical model toward modeling the formation of intra-luminal thrombus in abdominal aortic aneurysms. Front Physiol (2012) 0.88
Regulation of platelet plug formation by phosphoinositide metabolism. Blood (2013) 0.87
Visualizing the von Willebrand factor/glycoprotein Ib-IX axis with a platelet-type von Willebrand disease mutation. Blood (2009) 0.87
Platelets and atherogenesis: Platelet anti-aggregation activity and endothelial protection from tomatoes (Solanum lycopersicum L.). Exp Ther Med (2012) 0.87
Platelet recruitment to the inflamed glomerulus occurs via an alphaIIbbeta3/GPVI-dependent pathway. Am J Pathol (2010) 0.86
Contribution of blood platelets to vascular pathology in Alzheimer's disease. J Blood Med (2013) 0.85
Platelet dynamics in three-dimensional simulation of whole blood. Biophys J (2014) 0.85
P2X(1) receptor inhibition and soluble CD39 administration as novel approaches to widen the cardiovascular therapeutic window. Trends Cardiovasc Med (2009) 0.84
Unravelling the mechanism and significance of thrombin binding to platelet glycoprotein Ib. Thromb Haemost (2010) 0.84
Platelet hyaluronidase-2: an enzyme that translocates to the surface upon activation to function in extracellular matrix degradation. Blood (2014) 0.84
Chronic hepatitis B: role of anti-platelet therapy in inflammation control. Cell Mol Immunol (2015) 0.83
Coagulopathy during cardiac arrest and resuscitation in a swine model of electrically induced ventricular fibrillation. Resuscitation (2011) 0.83
Mechanobiology of platelets: techniques to study the role of fluid flow and platelet retraction forces at the micro- and nano-scale. Int J Mol Sci (2011) 0.83
Humanized mouse model of thrombosis is predictive of the clinical efficacy of antiplatelet agents. Circulation (2011) 0.83
Age-related changes in platelet function are more profound in women than in men. Sci Rep (2015) 0.82
The effect of upstream platelet-fibrinogen interactions on downstream adhesion and activation. Biomaterials (2011) 0.82
Migration distance-based platelet function analysis in a microfluidic system. Biomicrofluidics (2013) 0.81
Helicobacter pylori urease activates blood platelets through a lipoxygenase-mediated pathway. J Cell Mol Med (2009) 0.81
Association of the platelet GPIIb/IIIa polymorphism with atherosclerotic plaque morphology: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis (2011) 0.81
Involvement of platelet-tumor cell interaction in immune evasion. Potential role of podocalyxin-like protein 1. Front Oncol (2014) 0.81
GPVI and GPIbα mediate staphylococcal superantigen-like protein 5 (SSL5) induced platelet activation and direct toward glycans as potential inhibitors. PLoS One (2011) 0.80
Suppression of Aggrus/podoplanin-induced platelet aggregation and pulmonary metastasis by a single-chain antibody variable region fragment. Cancer Med (2014) 0.79
Differential surface activation of the A1 domain of von Willebrand factor. Biointerphases (2016) 0.78
Platelets induce apoptosis via membrane-bound FasL. Blood (2015) 0.77
Platelet adhesion to podoplanin under flow is mediated by the receptor CLEC-2 and stabilised by Src/Syk-dependent platelet signalling. Thromb Haemost (2015) 0.77
Hydrodynamic interaction between a platelet and an erythrocyte: effect of erythrocyte deformability, dynamics, and wall proximity. J Biomech Eng (2013) 0.77
Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with thrombocytopenia due to chronic bone marrow failure: a network meta-analysis and systematic review. Cochrane Database Syst Rev (2016) 0.77
Humanizing thrombi in mice. Trends Cardiovasc Med (2011) 0.77
Dynamic analysis of platelet deposition to resolve platelet adhesion receptor activity in whole blood at arterial shear rate. Platelets (2014) 0.77
The sGC stimulator riociguat inhibits platelet function in washed platelets but not in whole blood. Br J Pharmacol (2015) 0.76
Influenza Virus Infection Induces Platelet-Endothelial Adhesion Which Contributes to Lung Injury. J Virol (2015) 0.76
Antiplatelet medications and evolving antithrombotic medication. Skeletal Radiol (2013) 0.76
On-chip recalcification of citrated whole blood using a microfluidic herringbone mixer. Biomicrofluidics (2015) 0.76
Thrombocytopathy and type 2B von Willebrand disease. J Clin Invest (2013) 0.76
Continuing education course #2: current understanding of hemostasis. Toxicol Pathol (2010) 0.76
Crosslinking decreases the hemocompatibility of decellularized, porcine small intestinal submucosa. Acta Biomater (2014) 0.76
A factor VIII-derived peptide enables von Willebrand factor (VWF)-binding of artificial platelet nanoconstructs without interfering with VWF-adhesion of natural platelets. Nanoscale (2014) 0.76
Infection-associated platelet dysfunction of canine platelets detected in a flow chamber model. BMC Vet Res (2013) 0.76
Modulation of alpha-thrombin function by distinct interactions with platelet glycoprotein Ibalpha. Science (2003) 1.65
Binding of alpha-thrombin to surface-anchored platelet glycoprotein Ib(alpha) sulfotyrosines through a two-site mechanism involving exosite I. Proc Natl Acad Sci U S A (2011) 0.98
Unravelling the mechanism and significance of thrombin binding to platelet glycoprotein Ib. Thromb Haemost (2010) 0.84